Bostanex

DOSAGE AND ADMINISTRATION

Administration: BOSTANEX is administered orally. The dose can be taken with or without food. 

Dosage:

- Adults and adolescents 12 years of age and over: 1 tablet once daily. 

- Intermittent allergic rhinitis (presence of symptoms for less than 4 days per week or for less than 4 weeks) should be managed in accordance with the evaluation of patient's disease history and the treatment could be discontinued after symptoms are resolved and reinitiated upon their reappearance. 

- In persistent allergic rhinitis (presence of symptoms for 4 days or more per week and for more than 4 weeks), continued treatment may be proposed to the patients during the allergen exposure periods. 

- The safety and efficacy of deslortadin form film-coated tablet in children below the age of 12 years have not been established. It should be replaced by another dosage form.

CONTRAINDICATIONS

Hypersensitivity to desloratadine, loratadine or to any of the ingredients.  

WARNINGS AND PRECAUTIONS

In the case of severe renal insufficiency, desloratadine should be used with caution. 

Caution should be taken in patients having individual or family medical history of convulsion, especially in children, because convulsions may occur due to the effects of desloratadine.

BOSTANEX contains lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.

SHELF-LIFE: 36 months from the manufacturing date.

Box of 03 blisters x 10 film-coated tablets